Stocks
ALX Oncology Holdings (ALXO) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -11.9 | -5.06 | -4.86 | -0.71 | -0.72 | -10.3 | |||
| Changes by years, y/y, % | -87% | -57% | -4% | -85% | +1% | -61.9% | |||
ALX Oncology Holdings. P/FCF
ALX Oncology Holdings. P/FCF, changes, %
ALX Oncology Holdings (ALXO) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | -0.30 | -0.21 | -1.01 | -0.73 | -2.68 | -10.3 | ||
| Changes by years, y/y, % | -92% | -91% | +36% | +1% | +780% | |||
| Changes by quarters, q/q, % | -58% | -31% | +380% | -28% | +269% | |||
